ADMA Biologics, Inc.ADMANASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$2.05
Net Income/Share$0.88
Operating CF/Share$0.27
Free CF/Share$0.17
Cash/Share$0.26
Book Value/Share$1.81
Tangible Book/Share$1.79
Equity/Share$1.81
Interest Debt/Share$0.38
CapEx/Share$0.10
Dividend/Share$0.00
Valuation
Market Cap$4.16B
Enterprise Value$4.19B
P/E Ratio19.94P/S Ratio8.52P/OCF Ratio64.27
P/FCF Ratio102.27
P/B Ratio9.68P/TB Ratio9.68
EV/Sales8.57EV/EBITDA24.32
Graham Valuation
Graham Number$5.97
Graham Net-Net$0.53
Profitability
Earnings Yield5.02%FCF Yield0.98%ROE53.98%ROIC32.38%Return on Tangible Assets37.09%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF37.32%
CapEx/Revenue4.96%
CapEx/Depreciation2.89
SBC/Revenue4.11%
SG&A/Revenue0.00%
R&D/Revenue0.77%
Liquidity & Solvency
Debt/Equity0.19Debt/Assets0.15Debt/Market Cap0.02
Net Debt/EBITDA0.13
Current Ratio7.13Interest Coverage19.97xIncome Quality0.31Efficiency
Days Sales Outstanding103 days
Days Payables Outstanding40 days
Days Inventory324 days
Receivables Turnover3.55x
Payables Turnover9.21x
Inventory Turnover1.13x
Capital Structure
Tangible Assets$427.17M
Working Capital$346.17M
Invested Capital$428.97M
Intangibles/Assets0.71%